Point: were industry-sponsored roflumilast trials appropriate? Yes
- PMID: 24798830
- DOI: 10.1378/chest.14-0112
Point: were industry-sponsored roflumilast trials appropriate? Yes
Comment in
-
Rebuttal from Dr Rho et al.Chest. 2014 May;145(5):943-4. doi: 10.1378/chest.14-0115. Chest. 2014. PMID: 24798833 Free PMC article. No abstract available.
-
Roflumilast in COPD.Chest. 2015 Jul;148(1):e31. doi: 10.1378/chest.15-0664. Chest. 2015. PMID: 26149563 No abstract available.
Comment on
-
Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial.Lancet. 2005 Aug 13-19;366(9485):563-71. doi: 10.1016/S0140-6736(05)67100-0. Lancet. 2005. PMID: 16099292 Clinical Trial.
-
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.Lancet. 2009 Aug 29;374(9691):685-94. doi: 10.1016/S0140-6736(09)61255-1. Lancet. 2009. PMID: 19716960 Clinical Trial.
-
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.Lancet. 2009 Aug 29;374(9691):695-703. doi: 10.1016/S0140-6736(09)61252-6. Lancet. 2009. PMID: 19716961 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
